A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Anna Jaques Thrombotic Risk Profile (Client 8767)
Test Code9777CS
CPT Codes
85307, 85300, 85303, 85306, 81240, 86147 (x3), 85613<br>*** RESTRICTED USE *** This code is available for Client 8767 and 58240 only
Includes
Activated Protein C-Resistance
Antithrombin III Activity
Protein C Activity
Protein S Activity
Prothrombin (Factor II) 20210G>A Mutation Analysis
Cardiolipin Antibody (IgA)
Cardiolipin Antibody (IgG)
Cardiolipin Antibody (IgM)
dRVVT Screen
dRVVT Confirm
dRVVT 1:1 Mix
If dRVVT screen is prolonged (>45 seconds), the dRVVT Confirmation will be performed at an additional charge. If dRVVT Confirm is positive, a dRVVT 1:1 dilution will be performed at an additional charge.
Antithrombin III Activity
Protein C Activity
Protein S Activity
Prothrombin (Factor II) 20210G>A Mutation Analysis
Cardiolipin Antibody (IgA)
Cardiolipin Antibody (IgG)
Cardiolipin Antibody (IgM)
dRVVT Screen
dRVVT Confirm
dRVVT 1:1 Mix
If dRVVT screen is prolonged (>45 seconds), the dRVVT Confirmation will be performed at an additional charge. If dRVVT Confirm is positive, a dRVVT 1:1 dilution will be performed at an additional charge.
Preferred Specimen
7 mL plasma collected in a 3.2% sodium citrate (light blue-top) tube and
6 mL whole blood collected in an EDTA (lavender-top) or EDTA (royal blue-top) tube
6 mL whole blood collected in an EDTA (lavender-top) or EDTA (royal blue-top) tube
Minimum Volume
Whole blood: 3 mL
Plasma: 3.5 mL
Plasma: 3.5 mL
Instructions
See individual assays
Transport Temperature
Plasma: Frozen
Whole blood: Room temperature
Whole blood: Room temperature
Specimen Stability
Plasma
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 14 days
Whole blood
Room temperature: 8 days
Refrigerated: 8 days
Frozen: 30 days
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 14 days
Whole blood
Room temperature: 8 days
Refrigerated: 8 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
See individual assays
Methodology
See individual assays
FDA Status
This test was developed and its performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. Performance characteristics refer to the analytical performance of the test.
Setup Schedule
See individual assays
Clinical Significance
See individual assays